3'-deoxy-3'-C-trifluoromethyl nucleosides: Synthesis and antiviral evaluation

Nucleosides and Nucleotides

Volumn 17, Issue 12, 1998, Pages 2267-2280

  Lavaire, S ^a   Plantier Royon, R ^a   Portella, C ^a   De Monte, M ^b   Kirn, A ^b   Aubertin, A M ^b  

^a UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

3' FLUOROTHYMIDINE; NUCLEOSIDE ANALOG; RIBOSE; STAVUDINE; TRIFLURIDINE DERIVATIVE;

ANTIVIRAL ACTIVITY; ARTICLE; CHEMICAL REACTION; COXSACKIE VIRUS B4; CYTOMEGALOVIRUS; DERIVATIZATION; DRUG SCREENING; DRUG SYNTHESIS; HERPES SIMPLEX VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; VACCINIA VIRUS;

COXSACKIEVIRUS; CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS; HERPES; HUMAN HERPESVIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; VACCINIA; VACCINIA VIRUS;

EID: 0031727656     PISSN: 07328311     EISSN: None     Source Type: Journal    
DOI: 10.1080/07328319808004316     Document Type: Article

References (29)

1. (a) Mitsuya, H.; Broder, S. Proc. Natl. Acad. Sci. USA 1986, 83, 1911.
2. (b) Herdewijn, P.; Pauwels, R.; Baba, M.; Balzarini, J.; De Clercq, E. J. Med. Chem. 1987, 30, 2131.
3. (c) De Clercq, E. Adv. Drug. Res. 1988, 17, 1.
4. d) Nucleic Acids in Chemistry and Biology; Blackburn, G. M.; Gait, M. J. Eds; IRL: New-York, 1992.
5. (e) Dueholm, K. L.; Pedersen, E. B. Synthesis 1992, 1.
6. (f) Perigaud, C.; Gosselin, G.; Imbach, J. L. Nucleosides & Nucleotides 1992, 11, 903.
7. (g) Barrish, J. C.; Zahler, R. Ann. Rep. Med. Chem. 1993, 28, 131.
8. a) Horwitz, J. P.; Chua, J.; Da Rooge, M.; Noel, M.; Klundt, I. L. J. Org. Chem. 1966, 31, 205.
9. b) Lin, T. S.; Schinazi, R. F.; Prusoff, W.H. Biochem. Pharmacol. 1987, 36, 2713.
10. c) Mansuri, M. M.; Starrett, J. E.; Ghazzouli, I.; Hitchcock, M. J. M.; Sterzycki, R. Z.; Brankovan, V.; Lin, T. S.; August, E. M.; Prusoff, W. H.; Sommadossi, J. P.; Martin, J. C. J. Med. Chem. 1989, 32, 461.
11. d) Chen, B. C.; Quinlan, S. L.; Stark, R. S.; Reid, J. G.; Audia, V. H.; George, J. G.; Eisenreich, E.; Brundidge, S. P.; Racha, S.; Spector, R. H. Tetrahedron Lett. 1995, 36, 7957.
12. a) Ojima, I.; McCarthy, J. R.; Welch, J. T. Biomedical Frontiers of Fluorine Chemistry; ACS Symposium Series, 1996.
13. b) Welch, J. T.; Eswarakrishnan, S. Fluorine in Bioorganic Chemistry; John Wiley and Sons, Inc., 1991.
14. Motawia, M. S.; Pedersen, E. B. Liebigs Ann. Chem. 1990, 1137.
15. a) Morisawa, Y.; Yasuda, A.; Uchida, K. Jpn. Kokai Tokkyo Koho, Jp 02,270,893 (90,270,893) Chem. Abstr. 1991, 114, 143939w.
16. b) Johnson, C. R.; Bhumralkar, D. R.; De Clercq, E. Nucleosides & Nucleotides 1995, 14, 185.
17. c) Schmit, C. Synlett 1994, 241.
18. Lavaire, S.; Plantier-Royon, R.; Portella, C. J. Carbohydr. Chem. 1996, 15, 361.
19. Xie, M.; Berges, D. A.; Robbins, M. J. J. Org. Chem. 1996, 61, 5178.
20. a) Vorbrüggen, H.; Krolikiewicz, K.; Bennua, B. Chem. Ber. 1981, 114, 1234.
21. b) Vorbrüggen, H.; Höfle, G. Chem. Ber. 1981, 114, 1256.
22. Czernecki, S.; Valéry J. M. Synthesis 1991, 239.
23. Robbins, J. M.; Wilson, J. S.; Hansske, F. J. Amer. Chem. Soc. 1983, 105, 4059.
24. Negron, G.; Islas, G.; Diaz, Y.; Cruz, R.; Quiclet-Sire, B. Nucleosides & Nucleotides 1994, 13, 1011.
25. Seela, F.; Bourgeois, W. Synthesis 1990, 945.
26. Compounds 5a and 5b were tested against HSV-1 and did not exhibit activity, even at high concentration allowed by their low cytotoxicity. We thank D. Ingrand and J. Carquin (Lab. de Virologie, CHUR de Reims) for these measurements.
27. Moog, C.; Wick, A.; Le Ber, P.; Kirn, A.; Aubertin, A.-M. Antiviral Res. 1994, 24, 275.
28. Génu-Dellac, C.; Gosselin, G.; Aubertin, A.-M.; Ober, G.; Kirn, A.; Imbach, J.-L. Antiviral. Chem. Chemother. 1991, 2, 83.
29. Mosmann, T. J. Immunol. Methods 1983, 65, 55.